New Amsterdam stock jumps as LDL-C lowering drug scores again at Phase III
New Amsterdam Pharma’s obicetrapib has exceeded company expectations in the Phase III BROADWAY trial in adult patients with atherosclerotic cardiovascular…
All articles by Joshua Silverwood
Joshua Silverwood
-
-
Daiichi Sankyo secures breakthrough designation for NSCLC treatment
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Daiichi Sankyo for its antibody-drug conjugate (ADC)…
-
CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City
The CEO of US healthcare insurance firm UnitedHealthcare Group has been shot dead by a masked gunman outside of the…
-
Baxter signs over kidney care arm to investment firm in $3.5bn deal
US medtech giant Baxter has announced today (13 August) the signing of a definitive agreement divesting itself of the kidney…
-
Purdue receives clearance for opioid overdose injector for younger individuals
Purdue Pharma’s opioid overdose reversal injection, Zurnai, was granted clearance by the US Food and Drug Administration (FDA) for use…
-
Explainer: Labour has been elected in the UK – now what?
Following the announcement of the UK Labour Party’s near-landslide victory on 5 July, healthcare workers and life science investors have…
-
UK life science industry optimistically embraces Labour victory
With a Labour party victory across the UK, the life sciences industry will be expecting Keir Starmer’s party to make…
-
Explainer: US Election 2024 -Biden’s healthcare outlook
As a presidential election looms in the US, the incumbent democratic party has made strides to win over public, party…
-
Fujifilm invests $1.2bn ramping up North Carolina facility
Japanese medtech and imaging giant Fujifilm announced an investment of $1.2bn in its large-scale cell culture as it expands its…
-
Regulatory changes in the US and UK to watch in 2024
Significant regulatory changes across numerous medical fields are coming in 2024 with pharmaceutical and medical device companies urged to be…